Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Ashland Specialty Ingredients
EIR
•Ashland Specialty Ingredients•July 11, 2013

Ashland Specialty Ingredients – FDA EIR, Jul 11, 2013

Record Details

An FDA inspection of Ashland Specialty Ingredients, a manufacturer of active pharmaceutical ingredients (APIs), was conducted from July 9-11, 2013. The inspection, guided by Active Pharmaceutical Ingredient Process Inspection protocols, focused on Quality and Facilities & Equipment systems. Investigators identified significant issues, resulting in the issuance of an FDA Form 483. The primary violations included a failure to adequately investigate deviations. Specifically, the company did not conduct thorough investigations into out-of-trend microbiological results found in facility water, which exceeded established limits, nor did they investigate multiple instances of batch yield deviations for Allantoin that fell outside specifications. These omissions indicated a lapse in their quality control processes for identifying root causes and assessing product impact. Furthermore, the inspection revealed a lack of established written procedures to control access and manage changes within the laboratory's chromatography data system, which is critical for determining API purity. Both the Quality Systems Manager and a chemist had administrative access, raising data integrity concerns. In response to the observations, Ashland Specialty Ingredients committed to implementing corrections and submitting a formal written response within 15 days. Notably, during the inspection, the company voluntarily provided an approved procedure for data integrity and security for the chromatography system, addressing one of the identified shortcomings immediately.

Company
Ashland Specialty Ingredients
Inspection date
July 11, 2013
Product type
Biologics
Office
New Jersey District Office
People
  • John Devigili (recipient)
  • Nikki S. Ramirez (issuing_officer)
  • Nenita Castro (company_representative)
  • Michael R. Klapal (Investigator)
  • Wanda Gonzalez (recipient)
View Company Profile

ID · f2f5a555-a236-458d-980a-9d2dc37f7820

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Ashland Specialty Ingredients
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.